GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (OTCPK:RDTCF) » Definitions » Shares Outstanding (EOP)

RDTCF (Rapid Dose Therapeutics) Shares Outstanding (EOP) : 128.44 Mil (As of Nov. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Rapid Dose Therapeutics Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Rapid Dose Therapeutics's shares outstanding for the quarter that ended in Nov. 2024 was 128.44 Mil.

Rapid Dose Therapeutics's quarterly shares outstanding increased from Aug. 2024 (124.64 Mil) to Nov. 2024 (128.44 Mil). It means Rapid Dose Therapeutics issued new shares from Aug. 2024 to Nov. 2024 .

Rapid Dose Therapeutics's annual shares outstanding increased from Feb. 2023 (103.57 Mil) to Feb. 2024 (117.81 Mil). It means Rapid Dose Therapeutics issued new shares from Feb. 2023 to Feb. 2024 .


Rapid Dose Therapeutics Shares Outstanding (EOP) Historical Data

The historical data trend for Rapid Dose Therapeutics's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Dose Therapeutics Shares Outstanding (EOP) Chart

Rapid Dose Therapeutics Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 77.07 80.67 103.07 103.57 117.81

Rapid Dose Therapeutics Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 104.95 117.81 122.26 124.64 128.44

Competitive Comparison of Rapid Dose Therapeutics's Shares Outstanding (EOP)

For the Biotechnology subindustry, Rapid Dose Therapeutics's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rapid Dose Therapeutics's Shares Outstanding (EOP) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rapid Dose Therapeutics's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Rapid Dose Therapeutics's Shares Outstanding (EOP) falls into.


;
;

Rapid Dose Therapeutics Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Rapid Dose Therapeutics  (OTCPK:RDTCF) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Rapid Dose Therapeutics Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Rapid Dose Therapeutics's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Rapid Dose Therapeutics Business Description

Traded in Other Exchanges
Address
1121 Walkers Line, Unit 3, Burlington, ON, CAN, L7N 2G4
Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.

Rapid Dose Therapeutics Headlines

From GuruFocus

Rapid Dose Therapeutics Corp Announces Proposed Private Placement

By Business Wire Business Wire 05-26-2022

Rapid Dose Announces Filing of Corrective Disclosure

By Business Wire Business Wire 04-14-2023

Rapid Dose Announces Resumption of Trading on the CSE

By Business Wire Business Wire 05-04-2023

Rapid Dose Announces Change of Auditor

By Business Wire Business Wire 05-17-2023

Rapid Dose Announces Proposed Private Placement Financing

By Business Wire Business Wire 06-03-2023